首页> 外文期刊>European journal of human genetics: EJHG >Multiplex single-tube screening for mutations in the Nijmegen Breakage Syndrome (NBS1) gene in Hodgkin's and non-Hodgkin's lymphoma patients of Slavic origin.
【24h】

Multiplex single-tube screening for mutations in the Nijmegen Breakage Syndrome (NBS1) gene in Hodgkin's and non-Hodgkin's lymphoma patients of Slavic origin.

机译:多重单管筛查斯拉夫血型霍奇金淋巴瘤和非霍奇金淋巴瘤患者的奈梅亨断裂综合症(NBS1)基因突变。

获取原文
获取原文并翻译 | 示例
           

摘要

Patients with Nijmegen Breakage Syndrome (NBS) have a high risk to develop malignant diseases, most frequently B-cell lymphomas. It has been demonstrated that this chromosomal breakage syndrome results from mutations in the NBS1 gene that cause either a loss of full-length protein expression or expression of a variant protein. A large proportion of the known NBS patients are of Slavic origin who carry a major founder mutation 657del5 in exon 6 of the NBS1 gene. The prevalence of this mutation in Slav populations is reported to be high, possibly contributing to higher cancer risk in these populations. Therefore, if mutations in NBS1 are associated with higher risk of developing lymphoid cancers it would be most likely to be observed in these populations. A multiplex assay for four of the most frequent NBS1 mutations was designed and a series of 119 lymphoma patients from Slavic origin as well as 177 healthy controls were tested. One of the patients was a heterozygote carrier of the ACAAA deletion mutation in exon 6 (1/119). No mutation was observed in the control group, despite the reported high frequency (1/177). The power of this study was 30% to detect a relative risk of 2.0.European Journal of Human Genetics (2003) 11, 416-419. doi:10.1038/sj.ejhg.5200972
机译:奈梅亨断裂综合症(NBS)患者患恶性疾病的风险很高,最常见的是B细胞淋巴瘤。已经证明这种染色体断裂综合征是由NBS1基因的突变引起的,该突变引起全长蛋白质表达的丧失或变异蛋白的表达。大部分已知的NBS患者是斯拉夫血统的患者,他们在NBS1基因的第6外显子上携带主要的创始人突变657del5。据报道,这种突变在斯拉夫人群中的流行很高,可能导致这些人群患癌症的风险更高。因此,如果NBS1中的突变与发生淋巴癌的风险更高相关,则最有可能在这些人群中观察到。设计了针对四个最常见的NBS1突变的多重分析,并测试了119位来自斯拉夫血统的淋巴瘤患者以及177位健康对照。其中一名患者是外显子6(1/119)中ACAAA缺失突变的杂合子载体。尽管报道了高频率(1/177),但在对照组中未观察到突变。这项研究的功效为30%,可检测到2.0的相对风险.European Journal of Human Genetics(2003)11,416-419。 doi:10.1038 / sj.ejhg.5200972

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号